Editas Medicine
(NASDAQ) EDIT
Editas Medicine Financials at a Glance
Market Cap
$560.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$38.69M
Net Income (TTM)
-$108.95M
EPS (TTM)
-$1.22
P/E Ratio
-2.99
Dividend
$0.00
Beta (Volatility)
2.11 (High)
Dividend
$0.00
Beta (Volatility)
2.11 (High)
Price
$3.77
Volume
2,452,956.578
Open
$3.65
Price
$3.77
Volume
2,452,956.578
Open
$3.65
Previous Close
$3.65
Daily Range
$3.52 - $3.82
52-Week Range
$1.66 - $4.54
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
2.11 (High)
Price
$3.77
Volume
2,452,956.578
Open
$3.65
Previous Close
$3.65
Daily Range
$3.52 - $3.82
52-Week Range
$1.66 - $4.54
Estimated Earnings Date
Aug 11, 2026
EDIT News
EDIT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Editas Medicine
Industry
Biotechnology
Sector
Health CareEmployees
87
CEO
Gilmore O’Neill, MD
Website
www.editasmedicine.comHeadquarters
Cambridge, MA 02141, US
EDIT Financials
Key Financial Metrics (TTM)
Gross Margin
5.83%
Operating Margin
-297.50%
Net Income Margin
-281.59%
Return on Equity
-677.39%
Return on Capital
-95.52%
Return on Assets
-72.96%
Earnings Yield
-33.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$560.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
153.46M
Volume
2.45M
Avg. Volume
2.41M
Financials (TTM)
Gross Profit
$2.25M
Operating Income
-$115.11M
EBITDA
-$100.08M
Operating Cash Flow
-$140.50M
Capital Expenditure
-$585.00K
Free Cash Flow
-$141.09M
Cash & ST Invst.
$123.65M
Total Debt
$71.97M
Editas Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.83M
-39.2%
Gross Profit
$2.35M
+110.7%
Gross Margin
82.94%
N/A
Market Cap
$560.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$6.44M
N/A
Employees
87
N/A
Net Income
-$24.98M
+67.2%
EBITDA
-$23.43M
+67.4%
Quarterly Fundamentals
Total Cash
$123.65M
-44.0%
Total Debt
$71.97M
+131.2%
Accounts Receivable
$2.59M
+408.2%
Inventory
$0.00
N/A
Long Term Debt
$57.78M
+221.5%
Short Term Debt
$14.20M
+7.9%
Return on Assets
-72.96%
N/A
Return on Invested Capital
-1.05%
N/A
Free Cash Flow
-$23.15M
+51.7%
Operating Cash Flow
-$23.06M
+51.8%